TP53 and neoplasm: After NRASG12V activation in each of these models, we saw reduced tumorigenesis in both Lin28a/Tp53- and Lin28b/Tp53-DKO models (Figure 3, A and B), but neither model showed the degree of tumor prevention that was seen when both paralogs were deleted.